Beat it to death..........quinlash likes to compare Tier 1 (when it suits his needs), so below are recent numbers plus some US MSOs with price targets:
Company Share price PS ratio Sales 12 month price target
Tilray $4.06 3.1 $153 million $4.63
OGI $1.28 2.5 45 million $1.92
ACB $1.30 1.9 49 million $1.54
Weed $3.47 3.5 118 million $ 3.64
CURA $5.44 1.9 $340 million $10.54
TRU $9.10 1.0 301 million $37.45
Cresco $2.59 .6 304 million $8.63
Ayr $1.75 .2 120 million $12.79
Hexo $2.01 .5 $ 36 million $3.10 (in the real world)
First of all - ask yourself, do you really care about PS ratios?
TRU with quarterly sales of $300 million has a price target of $37.
AYR has a PS Ratio of .2, is .25 cents cheaper than Hexo, sales of $ 120 million and a price target of $ 12.79.
Does quinlash psoting Fintel have ANY credibility showing a price target of $37.00?
Or do the REAL analysts price target of $3.10 seem more realisitic in comparison tot he others?